Here it is: BioNtech's CEO says their vaccine is about 90% effective at the first interim analysis of 94 cases. They're submitting an application to US regulators in the third week of November
www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against